2012
Risk of more advanced cancer at surgery in African American men eligible for active surveillance.
Salmasi A, Han M, Kim I. Risk of more advanced cancer at surgery in African American men eligible for active surveillance. Journal Of Clinical Oncology 2012, 30: e15214-e15214. DOI: 10.1200/jco.2012.30.15_suppl.e15214.Peer-Reviewed Original ResearchActive surveillanceAdvanced cancerRadical prostatectomyProstate cancerNational Cancer InstituteAA menAfrican American menCaucasian manHigh riskCancer InstituteFavorable-risk prostate cancerPre-operative PSA levelLow-grade prostate cancerUnderwent radical prostatectomyRisk prostate cancerGrade prostate cancerJohns Hopkins Medical InstitutionsNCI criteriaPreoperative predictorsPSA levelsGrading of PCaPathological characteristicsSV involvementInclusion criteriaPositive cores
2010
Improved Testing for Microsatellite Instability in Colorectal Cancer Using a Simplified 3-Marker Assay
Esemuede I, Forslund A, Khan SA, Qin LX, Gimbel MI, Nash GM, Zeng Z, Rosenberg S, Shia J, Barany F, Paty PB. Improved Testing for Microsatellite Instability in Colorectal Cancer Using a Simplified 3-Marker Assay. Annals Of Surgical Oncology 2010, 17: 3370-3378. PMID: 20703819, PMCID: PMC3269820, DOI: 10.1245/s10434-010-1147-4.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaAdolescentAdultAgedAged, 80 and overBiological AssayBiomarkers, TumorColorectal NeoplasmsComparative Genomic HybridizationDNA RepairDNA Repair EnzymesFemaleFollow-Up StudiesGenetic TestingGerm-Line MutationHumansLymphatic MetastasisMaleMicrosatellite InstabilityMicrosatellite RepeatsMiddle AgedOligonucleotide Array Sequence AnalysisPrognosisProspective StudiesSurvival RateYoung AdultConceptsHereditary nonpolyposis colorectal cancerColorectal cancerMicrosatellite instabilityMSI testingMSI tumorsMismatch repair protein lossBackgroundIn colorectal cancerDisease-specific survivalPredictive scoring systemNonpolyposis colorectal cancerMore BRAF mutationsDefective DNA mismatch repairNCI criteriaFavorable prognosisFavorable survivalKRAS mutationsBRAF mutationsMSI statusDistinct phenotypic propertiesScoring systemCancerValuable markerMSS cancersMethodsDNA samplesProtein loss
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply